Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs American International Group Inc (AIG) Price & Performance

AbCellera Biologics Inc
American International Group Inc

Price performance

Price movement over the last 24 hours

Key statistics

AbCellera Biologics Inc vs American International Group Inc — how do they compare? AbCellera Biologics Inc trades at $7.19 (market cap $2.35B), while American International Group Inc trades at $79.64 (market cap $42.98B). The key difference: American International Group Inc is far larger — about 18.3× AbCellera Biologics Inc's market cap, and American International Group Inc pays a 2.47% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLAIG
Market Cap
$2.35B$42.98B
Sector
HealthFinancials
52-Week High
$8.12$86.59
52-Week Low
$2.78$71.89
Enterprise Value
$1.99B$50.68B
Dividend Yield
2.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbCellera Biologics Inc

AbCellera Biologics (ABCL) trades at $7.69, down 2.29% on the day, with strong analyst support (82% buy ratings) and a $9.67 consensus price target suggesting 26% upside. The stock shows bullish technical momentum with moving averages supporting the trend, though RSI levels indicate potential overbought conditions. Recent positive developments include a major $876 million collaboration with Jazz Pharmaceuticals and board expansions, offsetting concerns about negative cash flow and profitability metrics.

While ABCL faces significant fundamental challenges with negative margins and cash burn, the company's strong cash position ($626M) and recent strategic partnerships provide runway for growth. The primary investment thesis hinges on successful pipeline development and platform monetization, with risks centered on execution and path to profitability. Wall Street remains optimistic about the long-term platform value despite near-term financial headwinds.

American International Group Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About American International Group Inc

American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. Its revenue is split roughly evenly between commercial and consumer lines.

Read more on AIG